Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation therapies in immuno-oncology and immuno-inflammation...
Our mission is to allow greater access to treatments for the majority of immune-mediated disease patients who have mild to moderate symptoms...
At Exeliom Biosciences, we develop novel therapeutic approaches to unleashthe therapeutic potential of key players in the Microbiome - Host interactions to fightimmune-mediated diseases, starting with inflammatory bowel diseases